ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0637

Reduced IgG Sialic Acid Content: A Distinctive Characteristic of Symptomatic Anti-Nuclear Antibodies Positive Individuals

Carolina Munoz1, Sindu Johnson2, Zahi Touma1, Zareen Ahmad2, Dennisse Bonilla1, Linda Hiraki3, Arthur Bookman2 and Joan Wither4, 1Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada, 4Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, University of Toronto, Toronto, ON, Canada

Meeting: ACR Convergence 2022

Keywords: Autoantibody(ies), autoimmune diseases, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: SLE – Etiology and Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Currently the immune changes that lead to the transition from asymptomatic Anti-Nuclear Antibody (ANA) positivity to symptomatic disease are unknown. Studies in our laboratory revealed that increased levels of proinflammatory factors, particularly TNF-a, are restricted to symptomatic ANA+ individuals. Based upon this observation and the similarities between the ANA-associated SARDs (Systemic Lupus Erythematosus (SLE), Sjogren’s Syndrome, and Systemic Sclerosis) and Rheumatoid Arthritis, where progression from asymptomatic to symptomatic autoimmunity is associated with reduced sialylation of the IgG Fc region and accumulation of pro-inflammatory cytokines, herein we proposed to investigate whether or not a similar shift in sialylation occurs as asymptomatic ANA+ individuals progress to SARD.

Methods: An enzyme-linked lectin assay was developed that uses Sambucus Nigra Agglutinin, a lectin that binds sialic acid, to detect sialylated IgG. This assay was then used to determine the extent of sialylation on IgG purified from the plasma of 10 ANA– healthy controls (ANA–HC), 15 ANA+ asymptomatic (ANA+NS) individuals, and 15 SLE patients. Differences is the ability of the IgG to elicit inflammation between the ANA+ groups were investigated by stimulating monocyte derived dendric cells (moDC) from ANA–HC with aggregated IgG. IL-6 and TNF-a in the culture supernatants and serum were measured by ELISA. Cellular profiling of peripheral blood immune populations was performed using flow cytometry. Differences between the 3 groups were determined using the Kruskal-Wallis test followed by Dunn’s post-test for multiple comparisons. Correlations were assessed using Spearman’s correlation coefficient.

Results: The sialic acid content of IgG was significantly reduced in SLE patients compared to ANA+NS individuals (p= 0.02) and ANA–HC (p= 0.001) (Figure 1A). When moDC were stimulated with heat-aggregated IgG from ANA+NS and SLE patients, there was a trend to increased production of IL-6 and TNF-a, as compared to heat-aggregated IgG from ANA–HC, which was statically significant for TNF-a (p= 0.008) (Figure 1B) in SLE. There was a negative correlation between sialylation of IgG and serum levels of TNF-a (rho= -0.54, p= 0.004) (Figure 1C). The extent of IgG sialylation demonstrated a negative correlation with the levels of TNF-a produced in response to heat-aggregated IgG (rho= -0.5, p=0.02) (Figure 1D) and the proportion of T follicular 17 helper cells (rho= -0.37, p= 0.03) in the patients from which the IgG was purified (Figure 1E).

Conclusion: The reduced levels of sialylated IgG and their association with increased levels of TNF-a production in SLE patients, as compared to ANA+NS individuals and ANA–HC, are compatible with the concept that de-sialylation of IgG promotes the transition from asymptomatic to symptomatic autoimmunity in SARD.

Supporting image 1

Figure 1. Sialic acid content on IgG and its correlation with serum levels of TNF-, levels of TNF- produced in response to heat-aggregated IgG, and T follicular 17 helper cells.


Disclosures: C. Munoz, None; S. Johnson, None; Z. Touma, None; Z. Ahmad, None; D. Bonilla, None; L. Hiraki, None; A. Bookman, None; J. Wither, AstraZeneca, Pfizer.

To cite this abstract in AMA style:

Munoz C, Johnson S, Touma Z, Ahmad Z, Bonilla D, Hiraki L, Bookman A, Wither J. Reduced IgG Sialic Acid Content: A Distinctive Characteristic of Symptomatic Anti-Nuclear Antibodies Positive Individuals [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/reduced-igg-sialic-acid-content-a-distinctive-characteristic-of-symptomatic-anti-nuclear-antibodies-positive-individuals/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reduced-igg-sialic-acid-content-a-distinctive-characteristic-of-symptomatic-anti-nuclear-antibodies-positive-individuals/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology